“…Consistent with this idea, it is well-established that NMDAR expression and function are modulated by experience and various environmental factors, including developmental neurotoxins and some therapeutics (Neal et al, 2011;Wills et al, 2012;Alavian-Ghavanini et al, 2018;Repouskou et al, 2020;Engdahl et al, 2021a;Sheng et al, 2022). In addition, GRIN2B is a target for epigenetic control (Rodenas-Ruano et al, 2012;Gulchina et al, 2017;Alavian-Ghavanini et al, 2018;Loureiro et al, 2020;Engdahl et al, 2021a,b;Sheng et al, 2022). It is unclear the extent to which gene × environment interactions determine the symptomatic profile of this disease, but this will be an important avenue for future investigation.…”